We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Biomarkers Identified for Type 2 Diabetes

By LabMedica International staff writers
Posted on 24 Oct 2012
Print article
Novel biomarkers have been identified for type 2 diabetes that can serve as basis for developing new methods of treatment and prevention of this metabolic disease.

Metabolites in the blood have been characterized that will provide insight into the pathological mechanisms of type 2 diabetes and in addition can be used as biomarkers to determine the disease risk.

A scientific team at the German Institute of Human Nutrition (Potsdam-Rehbruecke, Germany) and the Max Delbrueck Center for Molecular Medicine (Berlin, Germany) studied 4,000 blood samples. At the time the blood sample was taken, none of the study participants suffered from type 2 diabetes. However, during the average follow-up time of seven years, 891 participants were diagnosed with type 2 diabetes. There were 76 participants in the study who were already classified at the beginning of the study as individuals at high risk for type 2 diabetes, but at the time the blood sample was taken, they were still healthy.

Flow injection analysis tandem mass spectrometry was used to quantify 163 metabolites per blood sample, including acylcarnitines, amino acids, hexose, and phospholipids, in baseline serum samples. Serum hexose; phenylalanine; and diacyl-phosphatidylcholines C32:1, C36:1, C38:3, and C40:5 were independently associated with increased risk of type 2 diabetes. Serum glycine; sphingomyelin C16:1; acyl-alkyl-phosphatidylcholines C34:3, C40:6, C42:5, C44:4, and C44:5; and lysophosphatidylcholine C18:2 were associated with decreased risk.

The metabolites significantly improved type 2 diabetes prediction compared with established risk factors. They were further linked to insulin sensitivity and secretion in one study group and were partly replicated in the independent cohort. The data indicate that metabolic alterations, including sugar metabolites, amino acids, and choline-containing phospholipids, are associated early on with a higher risk of type 2 diabetes.

Tobias Pischon, MD MPH, the lead author, said “At the same time the metabolites can also be used as biomarkers to precisely determine the risk of diabetes at a very early stage, since the study is based on prospective data, which is data that were collected before the onset of the disease. The results of the new metabolomic analysis thus provide a good basis for developing new treatment and prevention methods." The study was published on October 4, 2012, in the journal Diabetes.

Related Links:

German Institute of Human Nutrition
Max Delbrueck Center for Molecular Medicine


Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Coagulation Analyzer
CS-2400

Print article

Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.